Walleye Capital
AMED

Walleye Capital’s Amedisys AMED Stock Holding History

Walleye Capital’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-23,099
Closed -$2.12M – 5223
2024
Q2 		$2.12M Sell
23,099
-1,433
-6% -$133K ﹤0.01% 2047
2024
Q1 		$2.26M Buy
+24,532
New +$2.3M ﹤0.01% 1918
2023
Q2 		– Sell
-62,608
Closed -$4.6M – 4271
2023
Q1 		$4.6M Buy
+62,608
New +$5.42M 0.07% 349
2022
Q4 		– Sell
-2,700
Closed -$261K – 3149
2022
Q3 		$261K Sell
2,700
-4,855
-64% -$579K 0.01% 1931
2022
Q2 		$794K Sell
7,555
-16,542
-69% -$2.11M 0.02% 766
2022
Q1 		$4.15M Sell
24,097
-150
-0.6% -$22.4K 0.11% 193
2021
Q4 		$3.92M Sell
24,247
-16,927
-41% -$2.72M 0.12% 177
2021
Q3 		$6.14K Buy
+41,174
New +$8.56M 0.17% 66
2021
Q2 		– Sell
-3,657
Closed -$968 – 1326
2021
Q1 		$968 Buy
+3,657
New +$1.03M 0.06% 309

Other funds holding AMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $129B AUM 30.83% 1-Year Est. Return
WCMNY
Westchester Capital Management (New York) Valhalla, New York $2.21B AUM 26.02% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Walleye Capital's AMED Position: Q3 2024 in Review

Walleye Capital sold out of Amedisys (AMED) in Q3 2024, closing a stake of 23,099 shares — an estimated $2.12M sold.

Walleye Capital first reported a position in AMED in Q1 2021 and held it in 9 quarters. The position peaked at $4.6M in Q1 2023. 285 funds tracked by Wall St. Rank hold AMED as of Q3 2024.

  • Walleye Capital reported no remaining Amedisys position as of Q3 2024 after selling out during the quarter.
  • Walleye Capital sold 23,099 Amedisys shares in Q3 2024, an estimated $2.12M.
  • Walleye Capital first reported a position in Amedisys in Q1 2021 and held it in 9 quarters.
  • Walleye Capital's Amedisys position peaked at $4.6M in Q1 2023.
  • 285 funds tracked by Wall St. Rank held Amedisys as of Q3 2024.

Based on Walleye Capital's 13F filing for Q3 2024, filed 14 Nov 2024.